# US 2024/0182506 A1 · Sugar Derivatives and Uses Thereof to Prepare Novel Senolytic Agents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0182506 A1
- Document ID: US20240182506A1
- Status: Published application
- Kind: A1
- Application number: 18/403,174
- Filed: 2024-01-03
- Published: 2024-06-06
- Earliest claimed: 2021-09-13
- Assignees: Rubedo Life Sciences, Inc.
- Applicants: Rubedo Life Sciences, Inc.
- Inventors: Paul Keitz; Gus Bergnes; Mark A. Gallop; Marco Quarta
- Web page: https://patentgrep.com/patent/US20240182506A1

## CPC

- C07H 9/04: Cyclic acetals
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07H 3/02: Monosaccharides
- C07H 5/02: to halogen
- C07H 7/02: Acyclic radicals
- C07H 13/04: having the esterifying carboxyl radicals attached to acyclic carbon atoms
- C07H 15/04: attached to an oxygen atom of the saccharide radical
- C07H 15/26: Acyclic or carbocyclic radicals, substituted by hetero rings
- C07H 23/00: Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12 (esters with inorganic acids C07H11/00)
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Provided herein are novel sugar derivatives which are intermediates for preparing senolytic agents that selectively kill senescent cells associated with numerous pathologies and discases. including age-related pathologies and discases.

## Claims

### Claim at position 1

-20 (canceled)

### Claim 21

A compound of Formula (I) or Formula (II):
or pharmaceutically available salts, hydrate and solvates thereof, wherein:
R1 is —H or —C(O)R16;
R2 is —H or —OC(O)R9;
R3 is —H, —F, —OH, —OC(O)R11 or —OC(O)OR12;
R4 is —H, —F, —OH, —OC(O)R13 or —OC(O)OR14;
alternatively, both R3 and R4 together with the atoms to which they are bonded form a 5 membered cyclic acetal which is substituted by R19 at the acetal carbon;
alternatively, both R3 and R4 together with the atoms to which they are bonded form a 5 membered cyclic carbonate;
R5 is —CH3, —CH2OH, —OC(O)R17, —CH2F, or —OC(O)OR18;
R6 is —H or —F;
R7 is —H or —F;
R8 is —H or —F;
R9-R18 and are independently alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, cycloalkyl, substituted cycloalkyl, cycloalkenyl, substituted cycloalkenyl, cycloheteroalkyl, substituted cycloheteroalkyl, cycloheteroalkenyl, substituted cycloheteroalkenyl, heteroaryl or substituted heteroaryl; R19 is alkyl, substituted alkyl, aryl, substituted aryl, cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, substituted cycloheteroalkyl, heteroaryl or substituted heteroaryl;
provided that when R1 is H and R5 is —CH3 and R3 and R4 are —OH then R2 is not —H or —F;
provided that when R1 is H and R5 is —CH3 and R2 and R4 are —OH then R3 is not —H or —F;
provided that when R1 is H and R5 is —CH3 and R4 —H then R2 and R3 are not both —OH;
provided that when R1 —C(O)CH3, R2 is —F and R5 is —CH3 then R3 is not —F;
provided that when R1 is —C(O)CH3, R2 is —F and R5 is —CH3 then R3 and R4 are not both —OH, —OC(O)Ph or —OC(O)CH3;
provided that when R1 is —C(O)CH3, R4 is —F and R5 is —CH3 then R2 and R3 are not both —C(O)CH3;
provided that when R1 is —C(O)CH3, R2 is —F and R5 is —CH2OH or —OC(O)R17 then R3 and R4 are not both —OH;
provided that when R1 is —C(O)Ph, R2 is —F and R5 is —CH3 then R3 and R4 are not both —C(O)Ph; and
provided that when R1 is —C(O)Ph, R4 is —F and R5 is —CH3 then R2 and R3 are not both —C(O)Ph.

### Claim 22 (depends on 21)

The compound of claim 21, wherein R1 is not —C(O)Ph.

### Claim 23 (depends on 21)

The compound of claim 21, wherein R9, R11-R19 are independently alkyl, alkenyl, aryl, substituted aryl, cycloalkyl or cycloheteroalkyl.

### Claim 24 (depends on 21)

The compound of claim 21, wherein R9, R11-R19 are independently (C1-C4) alkyl, (C1-C4) alkenyl, phenyl, substituted phenyl, (C5-C7) cycloalkyl or (C5-C7) cycloheteroalkyl.

### Claim 25 (depends on 21)

The compound of claim 21, wherein R9, R11-R19 are independently (C1-C4) alkyl, (C1-C4) alkenyl, phenyl or substituted phenyl.

### Claim 26 (depends on 21)

The compound of claim 21, wherein R9, R11-R19 are independently (C1-C4) alkyl, (C1-C4) alkenyl, phenyl, substituted phenyl, benzyl or substituted benzyl.

### Claim 27

A compound having the structure:

### Claim 28

A compound having the structure:

### Claim 29

A compound having the structure:

### Claim 30

A compound having the structure:
